Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes | stella

Back to Type 1 Diabetes trials

Recruiting

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(17 sites)

United Kingdom

Aberdeen Royal Infirmary, Aberdeen

Addenbrookes Hospital, Cambridge

Ninewells Hospital, Dundee

Royal Infirmary of Edinburgh, Edinburgh

Glasgow Royal Infirmary, Glasgow Clinical Research Facility, Glasgow

Key details

Phase

Testing effectiveness

Sponsor

University of Dundee

Collaborators

Lexicon Pharmaceuticals, Juvenile Diabetes Research Foundation

Enrollment target

~320 participants

Started

January 2025

Primary completion

October 2027

Age range

18 Years – 84 Years

Last updated on clinicaltrials.gov in April 2026.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Ify Mordi, MBChB, MD

University of Dundee

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Enrollment status is pulled from ClinicalTrials.gov and may not reflect real-time availability. If a trial appears full when you reach out, the team will let you know.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov